Topimark 50 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

topimark 50 mg

glenmark pharmaceuticals s.r.o., Česká republika - topiramát - 21 - antiepileptica, anticonvulsiva

Topimark 100 mg Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

topimark 100 mg

glenmark pharmaceuticals s.r.o., Česká republika - topiramát - 21 - antiepileptica, anticonvulsiva

Moxifloxacin Kabi 400 mg/250 ml infúzny roztok Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

moxifloxacin kabi 400 mg/250 ml infúzny roztok

fresenius kabi s.r.o., Česká republika - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Moloxin 400 mg/250 ml infúzny roztok Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

moloxin 400 mg/250 ml infúzny roztok

krka, d.d., novo mesto, slovinsko - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Moloxin 400 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

moloxin 400 mg filmom obalené tablety

krka, d.d., novo mesto, slovinsko - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Kimoks 400 mg filmom obalené tablety Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

kimoks 400 mg filmom obalené tablety

alkaloid - int d.o.o., slovinsko - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Moxifloxacin MSN Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

moxifloxacin msn

vivanta generics s.r.o., Česká republika - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Avelox 400 Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

avelox 400

bayer ag - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Avelox 400 mg/250 ml infúzny roztok Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

avelox 400 mg/250 ml infúzny roztok

bayer ag, nemecko - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Onglyza Európska únia - slovenčina - EMA (European Medicines Agency)

onglyza

astrazeneca ab - saxagliptin - diabetes mellitus, typ 2 - lieky používané pri cukrovke - add-on combination therapyonglyza is indicated in adult patients aged 18 years and older with type-2 diabetes mellitus to improve glycaemic control:as monotherapy:in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance;as dual oral therapy:in combination with metformin, when metformin alone, with diet and exercise, does not provide adequate glycaemic control;in combination with a sulphonylurea, when the sulphonylurea alone, with diet and exercise, does not provide adequate glycaemic control in patients for whom use of metformin is considered inappropriate;in combination with a thiazolidinedione, when the thiazolidinedione alone with diet and exercise, does not provide adequate glycaemic control in patients for whom use of a thiazolidinedione is considered appropriate;as triple oral therapy:in combination with metformin plus a sulphonylurea when this regimen alone, with diet and exercise, does not provide adequate glycaemic control;as combination therapy with insulin (with or without metformin), when this regimen alone, with diet and exercise, does not provide adequate glycaemic control.